As of June 16, 2025, Encision Inc (ECIA) reports a ROE (Return on Equity) of -37.87%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Encision Inc's ROE (Return on Equity)
Over recent years, Encision Inc's ROE (Return on Equity) has shown a stable trend. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2024-03-31 | -37.87% |
| 2023-03-31 | -12.98% |
| 2022-03-31 | -2.39% |
| 2021-03-31 | 20.87% |
| 2020-03-31 | -9.08% |
This slight downward trend highlights how Encision Inc manages its efficiency in generating profits from shareholders' equity over time.
Comparing Encision Inc's ROE (Return on Equity) to Peers
To better understand Encision Inc's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Encision Inc (ECIA) | -37.87% |
| Hypertension Diagnostics Inc (HDII) | 96.89% |
| Caliber Imaging & Diagnostics Inc (LCDX) | 43.86% |
| Calmare Therapeutics Inc (CTTC) | 27.72% |
| Escalon Medical Corp (ESMC) | -6.92% |
| Precision Optics Corporation Inc (PEYE) | -10.35% |
Compared to its competitors, Encision Inc's ROE (Return on Equity) is about average compared to peers, reflecting standard industry returns on equity investment.